...
首页> 外文期刊>American Journal of Physiology >Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat.
【24h】

Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat.

机译:短链脂肪酸通过大鼠中的神经和多肽YY释放来改变结肠运动。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Short-chain fatty acids (SCFAs) are recognized as the major anions of the large intestinal content in humans, but their effect on colonic motility is controversial. This study explores the colonic motor effect of SCFAs and their mechanisms in the rat. Colonic motility (electromyography) and transit time (plastic markers) were measured in conscious rats while SCFAs were infused into the colon, either alone or after administration of neural antagonists or immunoneutralization of circulating polypeptide YY (PYY). SCFA-induced PYY release was measured by RIA and then simulated by infusing exogenous PYY. Intracolonic infusion of 0.4 mmol/h SCFAs had no effect, whereas 2 mmol/h SCFAs reduced colonic motility (36 +/- 3 vs. 57 +/- 4 spike bursts/h with saline, P < 0.05) by decreasing the ratio of nonpropulsive to propulsive activity. This resulted in an increased transit rate (P < 0.01). Neither alpha-adrenoceptor blockade nor nitric oxide synthase inhibition prevented SCFA-induced motility reduction. Intraluminal procaine infusion suppressed the SCFA effect, indicating that a local neural mechanism was involved. SCFA colonic infusion stimulated PYY release in blood. Immunoneutralization of circulating PYY abolished the effect of SCFAs on colonic motility, whereas exogenous PYY infusion partly reproduced this effect. SCFAs modify colonic motor patterns in the rat and increase transit rate; local nerve fibers and PYY are involved in this effect.
机译:短链脂肪酸(SCFA)被认为是人类大肠内容物中的主要阴离子,但它们对结肠运动的影响是有争议的。这项研究探讨了SCFAs在大鼠中的结肠运动作用及其机制。在清醒的大鼠中,将SCFA单独或在施用神经拮抗剂或免疫中和循环多肽YY(PYY)后,将清醒大鼠的结肠运动(肌电图)和通过时间(塑料标记)进行了测量。通过RIA测量SCFA诱导的PYY释放,然后通过注入外源PYY进行模拟。结肠内输注0.4 mmol / h SCFA无效,而2 mmol / h SCFA降低结肠的蠕动率(36 +/- 3 vs. 57 +/- 4尖峰冲击/h,P<0.05),其方式是降低对推进活动没有推动力。这导致增加的通过率(P <0.01)。 α-肾上腺素受体阻滞剂和一氧化氮合酶抑制均不能阻止SCFA诱导的运动能力降低。腔内注射普鲁卡因可抑制SCFA效应,表明参与了局部神经机制。 SCFA结肠输液刺激了PYY在血液中的释放。循环中PYY的免疫原化消除了SCFA对结肠运动的影响,而外源PYY输注部分重现了这种作用。 SCFA可以改变大鼠结肠运动模式,并提高转运速度;局部神经纤维和PYY参与此作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号